117 related articles for article (PubMed ID: 8551064)
21. Cytosolic tissue-type plasminogen activator (t-PA) levels in ductal infiltrating carcinomas of the breast classified according to different clinical and biological parameters.
García Muñiz JL; Alvarez A; Fernández Llana B; Fernández Raigoso P; Allende MT; Ruibal A
Int J Biol Markers; 1995; 10(2):119-21. PubMed ID: 7561238
[No Abstract] [Full Text] [Related]
22. [Valoration of the epidermal growth factor receptor (EGFR) in benign breast disease and its relation with expression in malignant tumors classified by hormonal dependence].
Allende MT; Raigoso PF; Alvarez A; Llana B; Sánchez A; Martínez MI; Miralles MT; Roiz C
Rev Esp Med Nucl; 1999; 18(1):32-6. PubMed ID: 10074215
[TBL] [Abstract][Full Text] [Related]
23. DNA and protein changes caused by disease in human breast tissues probed by the Kubelka-Munk spectral functional.
Yang Y; Celmer EJ; Koutcher JA; Alfano RR
Photochem Photobiol; 2002 Jun; 75(6):627-32. PubMed ID: 12081325
[TBL] [Abstract][Full Text] [Related]
24. Cytological analysis and immunocytochemical expression of Ki67 and Bcl-2 in breast proliferative lesions.
Midulla C; Pisani T; De Iorio P; Cenci M; Divizia E; Nofroni I; Vecchione A
Anticancer Res; 2002; 22(2B):1341-5. PubMed ID: 12168948
[TBL] [Abstract][Full Text] [Related]
25. Binding evaluation of Isoform 1 from Cratylia mollis lectin to human mammary tissues.
Beltrão EI; Correia MT; Figueredo-Silva J; Coelho LC
Appl Biochem Biotechnol; 1998 Sep; 74(3):125-34. PubMed ID: 10052113
[TBL] [Abstract][Full Text] [Related]
26. Expression of cyclooxygenase-2 in fine-needle aspirates from breast carcinoma and benign breast diseases.
Sucić M; Boban D; Marković-Glamocak M; Jakić-Razumović J; Vrbanec D; Ries S; Gjadrov-Kuvezdić K; Cobanov AM; Podolski P; Martinović I; Erak V; Budisić Z; Ivrlac R; Unusić J
Breast; 2003 Feb; 12(1):51-7. PubMed ID: 14659355
[TBL] [Abstract][Full Text] [Related]
27. [Steroid hormone receptors in the normal breast and in benign mastopathies].
Kouyoumdjian JC; Feuilhade F; Pinaudeau Y; Rymer JC
Bull Cancer; 1986; 73(2):120-3. PubMed ID: 3730631
[No Abstract] [Full Text] [Related]
28. Enhancer of Zeste 2 as a marker of preneoplastic progression in the breast.
Ding L; Kleer CG
Cancer Res; 2006 Oct; 66(19):9352-5. PubMed ID: 17018586
[TBL] [Abstract][Full Text] [Related]
29. Glial fibrillary acidic protein immunoreactivity in normal and diseased human breast.
Viale G; Gambacorta M; Coggi G; Dell'Orto P; Milani M; Doglioni C
Virchows Arch A Pathol Anat Histopathol; 1991; 418(4):339-48. PubMed ID: 1708927
[TBL] [Abstract][Full Text] [Related]
30. Tumor-associated overexpression of the soluble T1-S receptor in lymph node-negative breast cancer.
Werenskiold AK; Prechtel D; Harbeck N; Höfler H
Diagn Mol Pathol; 2000 Mar; 9(1):26-34. PubMed ID: 10718210
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical studies of S-100 protein expression in myoepithelial cells of benign breast diseases and normal breast tissues.
Umekita Y; Fujiyoshi T; Takasaki T; Kuriwaki K; Yoshida A; Yoshida H
In Vivo; 1993; 7(5):415-8. PubMed ID: 8110983
[TBL] [Abstract][Full Text] [Related]
32. Menstrual cycle-dependent variations of breast cyst fluid proteins and sex steroid receptors in the normal human breast.
Silva JS; Georgiade GS; Dilley WG; McCarty KS; Wells SA; McCarty KS
Cancer; 1983 Apr; 51(7):1297-302. PubMed ID: 6825052
[No Abstract] [Full Text] [Related]
33. [B cells and serum immunoglobulins in patients with breast pathology].
Zornoza G; Hernández JL; Sanz ML; Fernández J; Goena I; Lera JM
Rev Esp Oncol; 1981; 28(1):17-27. PubMed ID: 6984973
[TBL] [Abstract][Full Text] [Related]
34. Thrombospondin and other possible related matrix proteins in malignant and benign breast disease. An immunohistochemical study.
Wong SY; Purdie AT; Han P
Am J Pathol; 1992 Jun; 140(6):1473-82. PubMed ID: 1351369
[TBL] [Abstract][Full Text] [Related]
35. Histopathology of myoepithelial (basocellular) hyperplasias in adenosis and epitheliosis of the breast demonstrated by the reactivity of cytokeratins and S100 protein. An analysis of heterogenic cell proliferations in 90 cases of benign and malignant breast diseases.
Bässler R; Katzer B
Virchows Arch A Pathol Anat Histopathol; 1992; 421(5):435-42. PubMed ID: 1280883
[TBL] [Abstract][Full Text] [Related]
36. Shutter-speed analysis of contrast reagent bolus-tracking data: Preliminary observations in benign and malignant breast disease.
Li X; Huang W; Yankeelov TE; Tudorica A; Rooney WD; Springer CS
Magn Reson Med; 2005 Mar; 53(3):724-9. PubMed ID: 15723402
[TBL] [Abstract][Full Text] [Related]
37. Localisation of Ca and HMFG2 antigens in breast tissue by immunoperoxidase, immunofluorescence, and immunoelectron microscopy.
Beckford U; Barbatis C; Beesley JE; Linsell JC; Chantler SM
J Clin Pathol; 1985 May; 38(5):512-20. PubMed ID: 3889068
[TBL] [Abstract][Full Text] [Related]
38. Sarcoglycans in the normal and pathological breast tissue of humans: an immunohistochemical and molecular study.
Arco A; Favaloro A; Gioffrè M; Santoro G; Speciale F; Vermiglio G; Cutroneo G
Cells Tissues Organs; 2012; 195(6):550-62. PubMed ID: 22067288
[TBL] [Abstract][Full Text] [Related]
39. Cellular expression of growth hormone and prolactin receptors in human breast disorders.
Mertani HC; Garcia-Caballero T; Lambert A; Gérard F; Palayer C; Boutin JM; Vonderhaar BK; Waters MJ; Lobie PE; Morel G
Int J Cancer; 1998 Apr; 79(2):202-11. PubMed ID: 9583737
[TBL] [Abstract][Full Text] [Related]
40. p53 mutations in benign breast tissue.
Millikan R; Hulka B; Thor A; Zhang Y; Edgerton S; Zhang X; Pei H; He M; Wold L; Melton LJ
J Clin Oncol; 1995 Sep; 13(9):2293-300. PubMed ID: 7666086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
